Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion

Journal of Negative Results in BioMedicine

Volumn 10, Issue 1, 2011, Pages

  Naji, Franjo ^a   Sabovic, Miso ^b  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

atrial fibrillation; cardioversion; inflammation; lipoprotein(a)

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; LIPOPROTEIN A;

ADULT; ARTICLE; CARDIOVERSION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART SIZE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL; AGED; METABOLISM; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEIN(A); MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 81055150433     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-10-15     Document Type: Article

References (15)

1. Predictive value of admission electrocardiography in in patients with heart failure. Zareba KM, Shenkman HJ, Bisognano JD, Congest Heart Fail 2008 14 173 9 10.1111/j.1751-7133.2008.07528.x 18772621
2. Atrial fibrillation: strategies to control, combat and cure. Peters NS, Schilling RJ, Kanagaratnam P, Markides V, Lancet 2002 359 593 603 10.1016/S0140-6736(02)07748-6 11867130 (Pubitemid 34182838)
3. Blood pressure control and risk of incident atrial fibrillation. Thomas MC, Dublin S, Kaplan RC, Glazer NR, Lumley T, Longstreth WT Jr, Smith NL, Psaty BM, Siscovick DS, Heckbert SR, Am J Hypertens 2008 21 1111 6 10.1038/ajh.2008.248 18756257
4. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM, Card Electrophysiol Rev 2003 7 201 7 14739713 (Pubitemid 38256100)
5. Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control. Avitall B, Bi J, Mykytsey A, Chicos A, Heart Rhythm 2008 5 839 45 10.1016/j.hrthm.2008.02.042 18534368
6. Atrial fibrillation and obesity-results of a meta analysis. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS, Am Heart J 2008 155 310 5 10.1016/j.ahj.2007.10.004 18215602
7. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y, Circulation 2008 117 1249 51 10.1161/ CIRCULATIONAHA.107.760777 18332275 (Pubitemid 351372068)
8. Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: a transesophageal echocardiographic study. Igarashi Y, Yamamura M, Ito M, Inuzuka H, Ojima K, Aizawa Y, Am Heart J 1998 136 965 71 10.1016/S0002-8703(98)70151-6 9842008 (Pubitemid 29080853)
9. Lipoprotein(a), left atrial appendage function and thromboembolic risk in patients with chronic nonvalvular atrial fibrillation. Igarashi Y, Kasai H, Yamashita F, Sato T, Inuzuka H, Ojima K, Aizawa Y, Jpn Circ J 2000 64 93 8 10.1253/jcj.64.93 10716521 (Pubitemid 30136921)
10. Lipoprotein(a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, Broze GJ Jr, Simari RD, Blood 2001 98 2980 7 10.1182/blood.V98.10.2980 11698280
11. Female patients with atrial fibrillation have increased oxidized and glycated lipoprotein properties and lower apolipoprotein A-I expression in HDL. Kim SM, Lee JH, Kim JR, Shin DG, Lee SH, Cho KH, Int J Mol Med 2011 27 841 9 21399863
12. Lipoprotein(a): Current Perspectives. Gouni-Berthold I, Berthold HK, Curr Vasc Pharmacol 2011
13. Lipoprotein(a) and lipid profile in patients with atrial fibrillation. Diaz-Peromingo JA, Alban-Salgado A, Garcia-Suarez F, Sanchez-Leira J, Saborido-Frojan J, Iglesias-Gallego M, Med Sci Monit 2006 12 122 5
14. High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction. Shintani S, Kikuchi S, Hamaguchi H, Shiigai T, Stroke 1993 24 965 9 10.1161/01.STR.24.7.965 8322396 (Pubitemid 23201451)
15. Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein (a): evidence for a critical involvement of elements in its C-terminal domain. Klezovitch O, Edelstein C, Scanu AM, J Biol Chem 2001 276 46864 9 10.1074/jbc.M107943200 11591715